THAR PHARMACEUTICALS, INC.
🏢 View company profile →12Patents
12Active
12Granted
52Portfolio score
Filing activity: Feb 7, 2008 → Oct 7, 2013 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8399023B2 | Crystallization method and bioavailability | Chemistry; Metallurgy | 92 | Active |
| US8933057B2 | Crystallization method and bioavailability | Chemistry; Metallurgy | 88 | Active |
| US9169279B2 | Crystallization method and bioavailability | Human Necessities | 82 | Active |
| US8241371B2 | Method of creating crystalline substances | Performing Operations; Transporting | 11 | Active |
| US9340565B2 | Crystalline forms | Chemistry; Metallurgy | 4 | Active |
| US9334296B2 | Crystallization method and bioavailability | Chemistry; Metallurgy | 3 | Active |
| US8124603B2 | In vivo studies of crystalline forms of meloxicam | Human Necessities | 1 | Active |
| US8980868B2 | Oral forms of a phosphonic acid derivative | Chemistry; Metallurgy | 1 | Active |
| US9040535B2 | Crystalline molecular comlpexes of tadalafil | Human Necessities | 0 | Active |
| US8389512B2 | In vivo studies of crystalline forms of meloxicam | Human Necessities | 0 | Active |
| US8586587B2 | Crystalline molecular complex of tadalafil and methylparaben | Human Necessities | 0 | Active |
| US8486927B2 | Crystalline forms of lamotrigine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.